Ohio State team spots potential new fibromyalgia biomarkers; Life Tech brings biomarker expertise to companion Dx deal;

> Life Technologies ($LIFE) brings newly acquired biomarker expertise to its companion diagnostics collaboration deal with Merck Serono, putting into play technology it snatched up last October. Story

> Ohio State researchers developing a new fibromyalgia blood test say they've identified potential new biomarkers for the condition. More

> NEBA Health's new brain wave diagnostic for ADHD, which relies on a combined biomarker and clinical evaluation, won FDA clearance, in part, by proving the test is more accurate than clinical evaluation alone. Item

> Array BioPharma ($ARRY) is seeking a partner to fund further studies of its oral CRTH2 antagonist after promising Phase II results in patients with allergic asthma. Story

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.